Genelux Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GNLX Nasdaq 2834 https://genelux.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genelux Corp

After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) - Apr 5th, 2024 1:35 pm
All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy - Apr 4th, 2024 4:00 pm
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Apr 1st, 2024 11:00 am
Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX) - Dec 15th, 2023 8:01 pm
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer - Nov 27th, 2023 12:00 pm
Genelux Corporation (NASDAQ:GNLX) most popular amongst retail investors who own 57%, insiders hold 25% - Nov 17th, 2023 10:53 am
Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates - Nov 14th, 2023 10:50 pm
12 Best Performing Biotech Stocks in 2023 - Oct 20th, 2023 5:22 pm
Director John Thomas Sells 6667 Shares of Genelux Corp (GNLX) - Sep 19th, 2023 7:01 pm
Director John Smither Sells 900 Shares of Genelux Corp (GNLX) - Sep 15th, 2023 7:03 pm
10% Owner Aladar Szalay Sells 52,616 Shares of Genelux Corp (GNLX) - Sep 14th, 2023 5:21 pm
Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 14th, 2023 11:00 am
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - Sep 7th, 2023 8:01 pm
Genelux (NASDAQ:GNLX) Is In A Good Position To Deliver On Growth Plans - Aug 31st, 2023 3:14 pm
Genelux Corporation Announces New Chief Financial Officer - Aug 28th, 2023 11:00 am
Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates - Aug 14th, 2023 11:00 am
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023 - Aug 2nd, 2023 8:00 pm
10 Recent IPOs in 2023 to Consider - Aug 2nd, 2023 5:08 am
Why Shares of Genelux Climbed This Week - Jul 28th, 2023 2:54 pm
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires - Jul 20th, 2023 8:45 pm